Global Fibromyalgia Therapeutics Market Research Report 2016

November 2016 | 100 pages | ID: GAF37F3F61FEN
QYResearch

Abstracts

Notes:

Production, means the output of Fibromyalgia Therapeutics

Revenue, means the sales value of Fibromyalgia Therapeutics

This report studies Fibromyalgia Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Boehringer Ingelheim GmbH (Germany)
• Chelsea Therapeutics, Inc. (US)
• Claire Ellen Products, Inc. (US)
• Eli Lilly and Company (US)
• Forest Laboratories, Inc. (US)
• Impax Laboratories, Inc. (US)
• Meda AB (Sweden)
• Pfizer, Inc. (US)
• Pierre Fabre Medicament (France)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Fibromyalgia Therapeutics in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Fibromyalgia Therapeutics in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Fibromyalgia Therapeutics Market Research Report 2016

1 FIBROMYALGIA THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Fibromyalgia Therapeutics
1.2 Fibromyalgia Therapeutics Segment by Type
  1.2.1 Global Production Market Share of Fibromyalgia Therapeutics by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Fibromyalgia Therapeutics Segment by Application
  1.3.1 Fibromyalgia Therapeutics Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Fibromyalgia Therapeutics Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Fibromyalgia Therapeutics (2011-2021)

2 GLOBAL FIBROMYALGIA THERAPEUTICS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Fibromyalgia Therapeutics Production and Share by Manufacturers (2015 and 2016)
2.2 Global Fibromyalgia Therapeutics Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Fibromyalgia Therapeutics Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Fibromyalgia Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Fibromyalgia Therapeutics Market Competitive Situation and Trends
  2.5.1 Fibromyalgia Therapeutics Market Concentration Rate
  2.5.2 Fibromyalgia Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL FIBROMYALGIA THERAPEUTICS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Fibromyalgia Therapeutics Production and Market Share by Region (2011-2016)
3.2 Global Fibromyalgia Therapeutics Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL FIBROMYALGIA THERAPEUTICS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Fibromyalgia Therapeutics Consumption by Regions (2011-2016)
4.2 North America Fibromyalgia Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Fibromyalgia Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Fibromyalgia Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Fibromyalgia Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Fibromyalgia Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Fibromyalgia Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL FIBROMYALGIA THERAPEUTICS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Fibromyalgia Therapeutics Production and Market Share by Type (2011-2016)
5.2 Global Fibromyalgia Therapeutics Revenue and Market Share by Type (2011-2016)
5.3 Global Fibromyalgia Therapeutics Price by Type (2011-2016)
5.4 Global Fibromyalgia Therapeutics Production Growth by Type (2011-2016)

6 GLOBAL FIBROMYALGIA THERAPEUTICS MARKET ANALYSIS BY APPLICATION

6.1 Global Fibromyalgia Therapeutics Consumption and Market Share by Application (2011-2016)
6.2 Global Fibromyalgia Therapeutics Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL FIBROMYALGIA THERAPEUTICS MANUFACTURERS PROFILES/ANALYSIS

7.1 Boehringer Ingelheim GmbH (Germany)
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Boehringer Ingelheim GmbH (Germany) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Chelsea Therapeutics, Inc. (US)
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Chelsea Therapeutics, Inc. (US) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Claire Ellen Products, Inc. (US)
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Claire Ellen Products, Inc. (US) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Eli Lilly and Company (US)
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Eli Lilly and Company (US) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Forest Laboratories, Inc. (US)
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Forest Laboratories, Inc. (US) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Impax Laboratories, Inc. (US)
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Impax Laboratories, Inc. (US) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Meda AB (Sweden)
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Meda AB (Sweden) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Pfizer, Inc. (US)
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Pfizer, Inc. (US) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Pierre Fabre Medicament (France)
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Fibromyalgia Therapeutics Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Pierre Fabre Medicament (France) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview

8 FIBROMYALGIA THERAPEUTICS MANUFACTURING COST ANALYSIS

8.1 Fibromyalgia Therapeutics Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Fibromyalgia Therapeutics

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Fibromyalgia Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Fibromyalgia Therapeutics Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL FIBROMYALGIA THERAPEUTICS MARKET FORECAST (2016-2021)

12.1 Global Fibromyalgia Therapeutics Production, Revenue Forecast (2016-2021)
12.2 Global Fibromyalgia Therapeutics Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Fibromyalgia Therapeutics Production Forecast by Type (2016-2021)
12.4 Global Fibromyalgia Therapeutics Consumption Forecast by Application (2016-2021)
12.5 Fibromyalgia Therapeutics Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Fibromyalgia Therapeutics
Figure Global Production Market Share of Fibromyalgia Therapeutics by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Fibromyalgia Therapeutics Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Fibromyalgia Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Fibromyalgia Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Fibromyalgia Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Fibromyalgia Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Fibromyalgia Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Fibromyalgia Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Fibromyalgia Therapeutics Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Fibromyalgia Therapeutics Production of Key Manufacturers (2015 and 2016)
Table Global Fibromyalgia Therapeutics Production Share by Manufacturers (2015 and 2016)
Figure 2015 Fibromyalgia Therapeutics Production Share by Manufacturers
Figure 2016 Fibromyalgia Therapeutics Production Share by Manufacturers
Table Global Fibromyalgia Therapeutics Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Fibromyalgia Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Fibromyalgia Therapeutics Revenue Share by Manufacturers
Table 2016 Global Fibromyalgia Therapeutics Revenue Share by Manufacturers
Table Global Market Fibromyalgia Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Fibromyalgia Therapeutics Average Price of Key Manufacturers in 2015
Table Manufacturers Fibromyalgia Therapeutics Manufacturing Base Distribution and Sales Area
Table Manufacturers Fibromyalgia Therapeutics Product Type
Figure Fibromyalgia Therapeutics Market Share of Top 3 Manufacturers
Figure Fibromyalgia Therapeutics Market Share of Top 5 Manufacturers
Table Global Fibromyalgia Therapeutics Production by Regions (2011-2016)
Figure Global Fibromyalgia Therapeutics Production and Market Share by Regions (2011-2016)
Figure Global Fibromyalgia Therapeutics Production Market Share by Regions (2011-2016)
Figure 2015 Global Fibromyalgia Therapeutics Production Market Share by Regions
Table Global Fibromyalgia Therapeutics Revenue by Regions (2011-2016)
Table Global Fibromyalgia Therapeutics Revenue Market Share by Regions (2011-2016)
Table 2015 Global Fibromyalgia Therapeutics Revenue Market Share by Regions
Table Global Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table China Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table India Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Fibromyalgia Therapeutics Consumption Market by Regions (2011-2016)
Table Global Fibromyalgia Therapeutics Consumption Market Share by Regions (2011-2016)
Figure Global Fibromyalgia Therapeutics Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Fibromyalgia Therapeutics Consumption Market Share by Regions
Table North America Fibromyalgia Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Europe Fibromyalgia Therapeutics Production, Consumption, Import & Export (2011-2016)
Table China Fibromyalgia Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Japan Fibromyalgia Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Fibromyalgia Therapeutics Production, Consumption, Import & Export (2011-2016)
Table India Fibromyalgia Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Global Fibromyalgia Therapeutics Production by Type (2011-2016)
Table Global Fibromyalgia Therapeutics Production Share by Type (2011-2016)
Figure Production Market Share of Fibromyalgia Therapeutics by Type (2011-2016)
Figure 2015 Production Market Share of Fibromyalgia Therapeutics by Type
Table Global Fibromyalgia Therapeutics Revenue by Type (2011-2016)
Table Global Fibromyalgia Therapeutics Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Fibromyalgia Therapeutics by Type (2011-2016)
Figure 2015 Revenue Market Share of Fibromyalgia Therapeutics by Type
Table Global Fibromyalgia Therapeutics Price by Type (2011-2016)
Figure Global Fibromyalgia Therapeutics Production Growth by Type (2011-2016)
Table Global Fibromyalgia Therapeutics Consumption by Application (2011-2016)
Table Global Fibromyalgia Therapeutics Consumption Market Share by Application (2011-2016)
Figure Global Fibromyalgia Therapeutics Consumption Market Share by Application in 2015
Table Global Fibromyalgia Therapeutics Consumption Growth Rate by Application (2011-2016)
Figure Global Fibromyalgia Therapeutics Consumption Growth Rate by Application (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim GmbH (Germany) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim GmbH (Germany) Fibromyalgia Therapeutics Market Share (2011-2016)
Table Chelsea Therapeutics, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Chelsea Therapeutics, Inc. (US) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Chelsea Therapeutics, Inc. (US) Fibromyalgia Therapeutics Market Share (2011-2016)
Table Claire Ellen Products, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Claire Ellen Products, Inc. (US) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Claire Ellen Products, Inc. (US) Fibromyalgia Therapeutics Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company (US) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly and Company (US) Fibromyalgia Therapeutics Market Share (2011-2016)
Table Forest Laboratories, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Forest Laboratories, Inc. (US) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Forest Laboratories, Inc. (US) Fibromyalgia Therapeutics Market Share (2011-2016)
Table Impax Laboratories, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Impax Laboratories, Inc. (US) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Impax Laboratories, Inc. (US) Fibromyalgia Therapeutics Market Share (2011-2016)
Table Meda AB (Sweden) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Meda AB (Sweden) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Meda AB (Sweden) Fibromyalgia Therapeutics Market Share (2011-2016)
Table Pfizer, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer, Inc. (US) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Fibromyalgia Therapeutics Market Share (2011-2016)
Table Pierre Fabre Medicament (France) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pierre Fabre Medicament (France) Fibromyalgia Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pierre Fabre Medicament (France) Fibromyalgia Therapeutics Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Fibromyalgia Therapeutics
Figure Manufacturing Process Analysis of Fibromyalgia Therapeutics
Figure Fibromyalgia Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Fibromyalgia Therapeutics Major Manufacturers in 2015
Table Major Buyers of Fibromyalgia Therapeutics
Table Distributors/Traders List
Figure Global Fibromyalgia Therapeutics Production and Growth Rate Forecast (2016-2021)
Figure Global Fibromyalgia Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table Global Fibromyalgia Therapeutics Production Forecast by Regions (2016-2021)
Table Global Fibromyalgia Therapeutics Consumption Forecast by Regions (2016-2021)
Table Global Fibromyalgia Therapeutics Production Forecast by Type (2016-2021)
Table Global Fibromyalgia Therapeutics Consumption Forecast by Application (2016-2021)